Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review.
Sathianathen NJ, Philippou YA, Kuntz GM, Konety BR, Gupta S, Lamb AD, Dahm P.
Sathianathen NJ, et al.
BJU Int. 2019 Sep;124(3):370-372. doi: 10.1111/bju.14711. Epub 2019 Mar 20.
BJU Int. 2019.
PMID: 30763461
Review.
To provide a precis of the Cochrane Collaboration Review of taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. ...
To provide a precis of the Cochrane Collaboration Review of taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate can …